4//SEC Filing
Alkermes plc. 4
Accession 0001127602-17-014942
$ALKSCIK 0001520262operating
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 5:13 PM ET
Size
8.8 KB
Accession
0001127602-17-014942
Insider Transaction Report
Form 4
Alkermes plc.ALKS
Ehrich Elliot
SVP, R&D & CMO, Alkermes, Inc.
Transactions
- Exercise/Conversion
Ordinary Shares
2017-04-17$16.55/sh+10,000$165,500→ 65,071 total - Sale
Ordinary Shares
2017-04-17$56.60/sh−10,000$565,986→ 55,071 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2017-04-17−10,000→ 9,801 totalExercise: $16.55Exp: 2022-05-21→ Ordinary Shares (10,000 underlying)
Footnotes (4)
- [F1]This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.17 to $57.0975. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F4]These options are fully vested in accordance with their terms.
Documents
Issuer
Alkermes plc.
CIK 0001520262
Entity typeoperating
Related Parties
1- filerCIK 0001520262
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 5:13 PM ET
- Size
- 8.8 KB